Outcomes After Liver and Biliary Resection at a High-Volume Center

Sponsor
Azienda USL Toscana Centro
Study ID
NCT07556835
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Benign Liver Disease
  • Biliary Tract Diseases
  • Cholangiocarcinoma
  • Gallbladder Carcinoma
  • Hepatobiliary Diseases
  • Hepatocellular Carcinoma
  • Liver Metastases
  • Liver Metastases From Colorectal Cancer
  • Liver Neoplasms

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The goal of this observational study is to evaluate clinical and oncologic outcomes in adult patients undergoing liver and/or biliary resection for benign and malignant diseases. This study evaluates postoperative morbidity and mortality within 90 days after surgery, as well as overall survival and disease-free survival in patients with malignant disease. Participants will: * undergo standard surgical and perioperative management according to routine clinical practice * have clinical, surgical, and follow-up data collected from institutional medical records * be followed for postoperative outcomes and long-term oncologic outcomes up to 5 years

Key Dates

First listed
Apr 29, 2026
Start date
Apr 30, 2026
Status verified
Apr 2026
Primary completion
Jan 31, 2036
Completion
Dec 31, 2036

Study Design

Enrollment
1,000 participants (estimated)

Primary Outcome Measure

Postoperative morbidity at 30 days [ Time Frame: Within 30 days after surgery ]

Central Contacts

Find similar trials

Nationwide
Liver cancer trialsOncology trialsGI oncology trialsHepatology trials

Related Studies